Suchergebnisse - "Cubillo, Antonio"

PubPharm (7)

1

Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study

enthalten in: BMC cancer | 2024

von Elez, E. | Cubillo, A. | Alfonso, P. | +6

2

Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Yoo, C. | Javle, M. | Verdaguer Mata, H. | +17

3

Efficacy and safety of dilpacimab (ABT-165) versus bevacizumab plus FOLFIRI in metastatic colorectal cancer : a phase II study

enthalten in: Future oncology (London, England) | 2022

von Strickler, J. | Cubillo, A. | Liang, J. | +7

4

Randomized, double-blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer

enthalten in: Cancer medicine | 2018

von Fogelman, D. | Cubillo, A. | García-Alfonso, P. | +12

5

Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer

enthalten in: International journal of cancer | 2018

von Van Cutsem, E. | Hidalgo, M. | Canon, J. | +11

6

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses : A Phase 2 Randomized Clinical Trial

enthalten in: JAMA oncology | 2018

von Montagut, C. | Argilés, G. | Ciardiello, F. | +29

ErratumIn: JAMA Oncol. 2019 May 1;5(5):745. - PMID 31070664

7

Phase II Trial of Target-guided Personalized Chemotherapy in First-line Metastatic Colorectal Cancer

enthalten in: American journal of clinical oncology | 2016

von Cubillo, A. | Rodriguez-Pascual, J. | López-Ríos, F. | +10

1
[1]